Lonza to Acquire Five Merck KGaA CDMO Sites
ADC bioconjugation, viral vector, and LNP manufacturing capacity enters Lonza’s US network
Advertisement
ADC bioconjugation, viral vector, and LNP manufacturing capacity enters Lonza’s US network
Advertisement
Dr Constance Y. Fears, one of the speakers at our upcoming virtual event, discuses her career as a drug investigator and the FDA 483 Warning Letter trends
Boost sterility testing efficiency in manufacturing with automation, data management, and cost-saving strategies to ensure compliance and product safety.
Custom PCR and qPCR manufacturing to meet EMEA contract lab demands
Advertisement
Advertisement